Bile acid disease: the emerging epidemic
Oduyebo I & Camilleri M. Curr Opin Gastroenterol 2017;33:189–195.
Oduyebo I & Camilleri M. Curr Opin Gastroenterol 2017;33:189–195.
Type 2 (primary) bile acid diarrhoea (BAD) is associated with increased bile acid production and occurs in nearly 30% of patients with diarrhoea-predominant irritable bowel syndrome (IBS-D). Primary BAD is associated with disorders of serum fibroblast growth factor 19 (FGF-19) which results in excess bile acid synthesis by hepatocytes. This leads to higher concentrations of bile acids in the colon and increased faecal bile acid loss.
The tauroselcholic (75selenium) acid (SeHCAT) test is the most commonly used test for the diagnosis of BAD. A retention of SeHCAT of less than 10% is...
Job number: JB57410GBw(1) Date of Preparation: June 2020
How common is bile acid diarrhoea (BAD)?
Professor David S. Sanders
Professor Sanders argues that many patients presenting with irritable bowel syndrome (IBS) have underlying diseases. He explores a series of studies that suggest approximately 25% of patients presenting with IBS symptoms have BAD as the underlying cause.
Are you a healthcare professional?
This educational website is developed by GE Healthcare for educational purposes. The information contained within this website is intended for healthcare professionals. By entering this website you are confirming that you are a healthcare professional.
This link opens another website that is not under the review or control of GE Healthcare Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it.